Nektar Therapeutics
NKTR
S$30.42
Share price
-5.40%
Change (1 day)
1,565.27%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Total assets
Total assets on the balance sheet as of March 2025 : S$0.32 Billion
According to Nektar Therapeutics 's latest financial reports the company's total assets are S$0.32 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | S$0.41 B | -21.43% |
| 2023-12-31 | S$0.52 B | -44.82% |
| 2022-12-31 | S$0.95 B | -36.93% |
| 2021-12-31 | S$1.51 B | -25.81% |
| 2020-12-31 | S$2.03 B | -23.64% |
| 2019-12-31 | S$2.66 B | -9.25% |
| 2018-12-31 | S$2.93 B | 331.59% |
| 2017-12-31 | S$0.68 B | -17.33% |
| 2016-12-31 | S$0.82 B | 16.73% |
| 2015-12-31 | S$0.70 B | 20.88% |
| 2014-12-31 | S$0.58 B | 5.99% |
| 2013-12-31 | S$0.55 B | -9.56% |
| 2012-12-31 | S$0.60 B | -22.5% |
| 2011-12-31 | S$0.78 B | 17% |
| 2010-12-31 | S$0.67 B | -16.9% |
| 2009-12-31 | S$0.80 B | 0.79% |
| 2008-12-31 | S$0.80 B | -23.17% |
| 2007-12-31 | S$1.04 B | -11.42% |
| 2006-12-31 | S$1.17 B | -17.6% |
| 2005-12-31 | S$1.42 B | 17.63% |
| 2004-12-31 | S$1.21 B | 15.97% |
| 2003-12-31 | S$1.04 B | -0.45% |
| 2002-12-31 | S$1.05 B | -14.78% |
| 2001-12-31 | S$1.23 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | S$114.93 B | 34,776.15% | 🇺🇸 USA |
 Pfizer PFE | S$267.54 B | 81,084.51% | 🇺🇸 USA |
 Merck MRK | S$148.05 B | 44,827.24% | 🇺🇸 USA |
 Richardson Electronics RELL | S$0.24 B | -25.93% | 🇺🇸 USA |
 AstraZeneca AZN | S$136.65 B | 41,366.04% | 🇬🇧 UK |
 Baxter BAX | S$27.39 B | 8,214.05% | 🇺🇸 USA |
 Alkermes ALKS | S$2.67 B | 712.51% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | S$249.08 B | 75,481.58% | 🇺🇸 USA |